Atlas Trials

A Pharmacokinetic Study of Omaveloxolone in Subjects With Hepatic Impairment and Normal Hepatic Function

Clinical trial NCT03902002 · COMPLETED

Trial details

NCT number
NCT03902002
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2019-07-19
Primary completion
2020-01-27
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.